This content is machine translated Pulmonary arterial hypertension beyond the guideline. IPAH or what else? – IPAH with pulmonary comorbidity Pulmonary hypertension is divided into five different groups, with group 1 reflecting pulmonary arterial hypertension (PAH). The PH-specific drug therapies approved to date interfere with three different signaling pathways (NO… CME-Test
View Post 10 min This content is machine translated Pulmonary arterial hypertension beyond the guideline. IPAH or what else? – IPAH with pulmonary comorbidity Pulmonary hypertension is divided into 5 distinct groups, with group 1 reflecting pulmonary arterial hypertension (PAH). The PH-specific drug therapies approved to date interfere with three different signaling pathways (NO… CME-Test
View Post 12 min This content is machine translated Genetics of pulmonary arterial hypertension. Basics, diagnostics and a new molecular therapeutic approach Pulmonary hypertension (PH) affects approximately 1% of the world’s population. It is associated with a poor prognosis for patients. Various causes condition right ventricular afterload increase, which can lead to… CME-Test
View Post 4 min This content is machine translated Pulmonary hypertension The specific therapy remains complex In a seminar at this year’s KHM Congress, PD Dr. med. Silvia Ulrich Somaini, University Hospital Zurich, provided information on the most important aspects of pulmonary hypertension and how patients…
View Post 8 min This content is machine translated Current therapy of COPD Therapeutic nihilism is out of place The diagnosis of COPD is often made at an advanced stage. Earlier diagnosis, which would lead to a significant improvement in prognosis, requires screening spirometrics in the primary care physician’s…
